BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25413005)

  • 1. Oxidized derivative of docosahexaenoic acid preferentially inhibit cell proliferation in triple negative over luminal breast cancer cells.
    Pogash TJ; El-Bayoumy K; Amin S; Gowda K; de Cicco RL; Barton M; Su Y; Russo IH; Himmelberger JA; Slifker M; Manni A; Russo J
    In Vitro Cell Dev Biol Anim; 2015 Feb; 51(2):121-7. PubMed ID: 25413005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Docosahexaenoic Acid on Cell Cycle Pathways in Breast Cell Lines With Different Transformation Degree.
    Rescigno T; Capasso A; Tecce MF
    J Cell Physiol; 2016 Jun; 231(6):1226-36. PubMed ID: 26480024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymeric nanocapsules prevent oxidation of core-loaded molecules: evidence based on the effects of docosahexaenoic acid and neuroprostane on breast cancer cells proliferation.
    Roy J; Oliveira LT; Oger C; Galano JM; Bultel-Poncé V; Richard S; Guimaraes AG; Vilela JM; Andrade MS; Durand T; Besson P; Mosqueira VC; Le Guennec JY
    J Exp Clin Cancer Res; 2015 Dec; 34():155. PubMed ID: 26689718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel biologically active acid stable liposomal formulation of docosahexaenoic acid in human breast cancer cell lines.
    Skibinski CG; Das A; Chen KM; Liao J; Manni A; Kester M; El-Bayoumy K
    Chem Biol Interact; 2016 May; 252():1-8. PubMed ID: 27041074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone.
    Altenburg JD; Bieberich AA; Terry C; Harvey KA; Vanhorn JF; Xu Z; Jo Davisson V; Siddiqui RA
    BMC Cancer; 2011 Apr; 11():149. PubMed ID: 21510869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous supplementation with omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA; 22:6n-3) synergistically enhances taxane cytotoxicity and downregulates Her-2/neu (c-erbB-2) oncogene expression in human breast cancer cells.
    Menendez JA; Lupu R; Colomer R
    Eur J Cancer Prev; 2005 Jun; 14(3):263-70. PubMed ID: 15901996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Ratios of Omega Fatty Acids (AA/EPA+DHA) Modulate Growth, Lipid Peroxidation and Expression of Tumor Regulatory MARBPs in Breast Cancer Cell Lines MCF7 and MDA-MB-231.
    Mansara PP; Deshpande RA; Vaidya MM; Kaul-Ghanekar R
    PLoS One; 2015; 10(9):e0136542. PubMed ID: 26325577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docosahexaenoic acid-acylated phloridzin, a novel polyphenol fatty acid ester derivative, is cytotoxic to breast cancer cells.
    Fernando W; Coombs MRP; Hoskin DW; Rupasinghe HPV
    Carcinogenesis; 2016 Oct; 37(10):1004-1013. PubMed ID: 27535497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.
    Siddiqui RA; Harvey KA; Xu Z; Natarajan SK; Davisson VJ
    Bioorg Med Chem; 2014 Mar; 22(6):1899-908. PubMed ID: 24556504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docosahexaenoic acid suppresses migration of triple-negative breast cancer cell through targeting metastasis-related genes and microRNA under normoxic and hypoxic conditions.
    Javadian M; Shekari N; Soltani-Zangbar MS; Mohammadi A; Mansoori B; Maralbashi S; Shanehbandi D; Baradaran B; Darabi M; Kazemi T
    J Cell Biochem; 2020 Mar; 121(3):2416-2427. PubMed ID: 31713924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells.
    Schley PD; Jijon HB; Robinson LE; Field CJ
    Breast Cancer Res Treat; 2005 Jul; 92(2):187-95. PubMed ID: 15986129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of docosahexaenoic acid in enhancement of docetaxel action in patient-derived breast cancer xenografts.
    Newell M; Goruk S; Mazurak V; Postovit L; Field CJ
    Breast Cancer Res Treat; 2019 Sep; 177(2):357-367. PubMed ID: 31236812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clathrin-mediated endocytic uptake of PUFA enriched self-nanoemulsifying lipidic systems (SNELS) of an anticancer drug against triple negative cancer and DMBA induced preclinical tumor model.
    Khurana RK; Kumar R; Gaspar BL; Welsby G; Welsby P; Kesharwani P; Katare OP; Singh KK; Singh B
    Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():645-658. PubMed ID: 30033299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega 3-DHA and Delta-Tocotrienol Modulate Lipid Droplet Biogenesis and Lipophagy in Breast Cancer Cells: the Impact in Cancer Aggressiveness.
    Pizato N; Kiffer LFMV; Luzete BC; Assumpção JAF; Correa LH; Melo HAB; Sant'Ana LP; Ito MK; Magalhães KG
    Nutrients; 2019 May; 11(6):. PubMed ID: 31141912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of docosahexaenoic acid synergistically enhances the efficacy of apatinib for triple-negative breast cancer therapy.
    Ma Y; Yu J; Li Q; Su Q; Cao B
    Biosci Biotechnol Biochem; 2020 Apr; 84(4):743-756. PubMed ID: 31889475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical-physical changes in cell membrane microdomains of breast cancer cells after omega-3 PUFA incorporation.
    Corsetto PA; Cremona A; Montorfano G; Jovenitti IE; Orsini F; Arosio P; Rizzo AM
    Cell Biochem Biophys; 2012 Sep; 64(1):45-59. PubMed ID: 22622660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
    Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer effects of synthetic hexahydrobenzo [g]chromen-4-one derivatives on human breast cancer cell lines.
    Pordeli M; Nakhjiri M; Safavi M; Ardestani SK; Foroumadi A
    Breast Cancer; 2017 Mar; 24(2):299-311. PubMed ID: 27250840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyunsaturated fatty acids inhibit melanoma cell growth in vitro.
    Zajdel A; Wilczok A; Chodurek E; Gruchlik A; Dzierzewicz Z
    Acta Pol Pharm; 2013; 70(2):365-9. PubMed ID: 23614295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.